Drug-induced linear IgA bullous dermatosis associated with ceftriaxone- and metronidazole-specific T cells

Dermatology

Volumn 199, Issue 1, 1999, Pages 25-30

  Yawalkar, N ^a   Reimers, A ^b   Hari, Y ^b   Hunziker, Th ^b   Gerber, H ^b   Muller U ^b   Pichler, W ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b NONE

Author keywords

Ceftriaxone; Cytokines; Linear IgA bullous dermatosis; Metronidazole; T cells

Indexed keywords

CD8 ANTIGEN; CEFTRIAXONE; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN A ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 5; METRONIDAZOLE; TUMOR NECROSIS FACTOR ALPHA;

AGED; ARTICLE; BULLOUS SKIN DISEASE; CASE REPORT; CHOLECYSTITIS; CHOLELITHIASIS; DRUG INDUCED DISEASE; FEMALE; FLOW CYTOMETRY; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; PATCH TEST; PATHOGENESIS; PRIORITY JOURNAL; SENSITIZATION; SKIN DEFECT; T LYMPHOCYTE;

AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; CD8-POSITIVE T-LYMPHOCYTES; CEFTRIAXONE; CELL DIVISION; FEMALE; GALLBLADDER DISEASES; HLA-DR ANTIGENS; HUMANS; IMMUNOGLOBULIN A; INTERFERON TYPE II; INTERLEUKIN-5; METRONIDAZOLE; SKIN; SKIN DISEASES, VESICULOBULLOUS; SKIN TESTS; T-LYMPHOCYTES;

EID: 0032770029     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000018173     Document Type: Article

References (16)

1. Collier PM, Wojnarowska F: Drug-induced linear immunoglobulin A disease. Clin Dermatol 1993;11:529-533.
2. Wakelin SH, Allen J, Zhou S, Wojnarowska F: Drug-induced linear IgA disease with antibodies to collagen VII. Br J Dermatol 1998;138: 310-314.
3. Wilkinson DS, Fregert S, Magnusson B, Bandmann HJ, Calnan CD, Cronin E, Hjorth N, Maibach HJ, Malalten KE, Meneghin CL, Pirila V: Terminology of contact dermatitis. Acta Derm Venereol 1970;50:287-292.
4. Nyfeler B, Pichler W: The lymphocyte transformation test for diagnosis of drug allergy: Sensitivity and specificity. Clin Exp Allergy 1997;27:175-181.
5. Elsasser-Beile U, von Kleist S, Gallati H: Evaluation of a test for measuring cytokine production in human whole blood cell cultures. J Immunol Methods 1991;139:191-195.
6. Ulfgren AK, Lindblad S, Klareskog L, Andersson J, Andersson U: Detection of cytokine producing cells in the synovial membrane from patients with rheumatoid arthritis. Ann Rheum Dis 1995;54:654-661.
7. Hunziker Th, Ortrun MM: Autoimmunopathien der Haut; in Peter HH, Pichler WJ (eds): Klinische Immunologie, ed 2. München, Urban & Schwarzenberg, 1996, pp 572-587.
8. Kim PH, Kagnoff MF: Transforming growth factor β1 increases IgA isotype switching at the clonal level. J Immunol 1990;145:3773-3778.
9. Van Vlasselaer P, Punnonen J, de Vries JE: Transforming growth factor-β directs IgA switching in human B cells. J Immunol 1992; 148:2062-2067.
10. Murray PD, McKenzie DT, Swain SL, Kagnoff MF: Interleukin 5 and interleukin 4 produced by Peyer's patch T cells selectively enhance immunoglobulin A expression. J Immunol 1987; 139:2669-2674.
11. Schoenbeck S, McKenzie DT, Kagnoff MF: Interleukin 5 is a differentiation factor for IgA B cells. Eur J Immunol 1989;19:965-969.
12. Kunimoto DY, Nordan RP, Strober W: IL-6 is a potent cofactor of IL-1 in IgM synthesis and of IL-5 in IgA synthesis. J Immunol 1989;143: 2230-2235.
13. Beagley KW, Eldridge JH, Lee F, Kiyono H, Everson MP, Koopman WJ, Hirano T, Kishimoto T, McGhee JR: Interleukins and IgA synthesis: Human and murine interleukin 6 induce high rate IgA secretion in IgA-committed B cells. J Exp Med 1989;169:2133-2138.
14. Briere F, Bridon JM, Chevet D, Soillet G, Bienvenu F, Guret C, Martinez-Valdez H, Banchereau J: Interleukin 10 induces B lymphocytes from IgA-deficient patients to secrete IgA. J Clin Invest 1994;94:97-104.
15. Caproni M, Feliciani C, Fuligni A, Salvatore E, Atani L, Bianchi B, Mohammad Pour S, Proietto G, Toto P, Coscione G, Amerio P, Fabbri P: Th2-like cytokine activity in dermatitis herpetiformis. Br J Dermatol 1998;138:242-247.
16. Schnyder B, Frutig K, Yawalkar N, Limat A, Pichler WJ: T cell cytotoxicity in sulfamethoxazole induced skin reaction. Clin Exp Allergy 1998;28:1412-1417.